Progressive Supranuclear Palsy study: Stimulation Arm
Official title tDCS as Treatment for Motor Function
ClinicalTrials.gov ID: NCT07291687
What this study is testing
- What it's testing
- The study wants to see whether walking sessions combined with tDCS improve gait, speech, eye movement, and hand dexterity. It also checks if the effect appears in several related disorders.
- Who it's for
- Adults diagnosed with progressive supranuclear palsy, cortical basal ganglionic degeneration, or Parkinson disease.
- What's involved
- Participants will receive transcranial direct current stimulation (a mild electrical current to the scalp) while they do walking training, and their motor abilities will be measured.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults
You may be able to join if
- \- 1. Participants must be able to walk unassisted, or with the assistance of a walker or cane, and be individuals who walk daily.
- 2\. Participants should have a sufficient level of English to be able to express themselves verbally, be able to read and follow instructions.
You likely can't join if
- 3\. Individuals with metal implants within the brain such as shunts will be excluded.
The study team makes the final eligibility decision.
Where it is enrolling
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.